Microdosing LSD is taking low doses of the drug to boost creativity, mood, and cognition. However, LSD is likely to stay illegal as it can be difficult to manage in case of overdose. BioPharm is developing safer alternatives that have similar benefits but plateau at a manageable level of intensity. These products could improve the quality of life for millions of people.
MDMA has been investigated as a potential treatment for various psychiatric disorders, such as post-traumatic stress disorder (PTSD), anxiety, depression, and addiction. However, MDMA can cause long-term damage to the brain and the heart, creating the opportunity to develop safer, less toxic alternatives.
Psychoactive Drug Designer Matt Bowden responded today to reporting of Auckland University’s study on LSD micro-dosing having potential sleep benefits, warning the public that LSD in normal doses can cause sleep disturbance on the day of usage, and adding that safer alternatives may need to be developed before public usage of psychedelic drugs.
Veteran drug policy reformer Matt Bowden suggested certain synthetic cannabinoids should be explored as substitute drugs in Fentanyl crisis, and corrected misinformation that his company had invented synthetic cannabinoid 5f-pb-22 which caused 4 deaths in USA.
Auckland parents of Hollie MacCullaich were shocked after the six month old started showing signs of a form of epilepsy which causes lasting brain damage. Now two years old, Hollie’s seizures became a weekly occurrence, with mental development effectively halted at six months old, and parents being told permanent damage was occurring. “After you hit…
This is the question health regulators are struggling with, and a key question anybody purchasing hemp derived products needs to ask themselves also. First, what is all the fuss about? Why does agricultural CBD contain arsenic and lead?
A Study published in the Journal of the American Medical Association slammed suppliers of ‘natural’ CBD products after most products were found to be contaminated with illegal drug THC, the psychoactive component of cannabis.
PepsiCo have admitted they have an interest in the CBD beverage market expected to grow to $2.5 Billion by 2023, but analysts note they stay tight lipped to avoid conflict with American regulating authorities. However, if the intel from food technology R & D departments of Pepsi, Red Bull and Monster is anything to go by, it is full steam ahead in product development, whether for the USA domestic market, or the global arena as we trend toward acceptance of clean CBD as a safe food additive.
